Transcriptional activation of estrogen receptor ERα and ERβ by polycyclic musks is cell type dependent

被引:58
|
作者
Schreurs, RHMM
Quaedackers, ME
Seinen, W
van der Burg, B
机构
[1] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands
[2] Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands
关键词
estrogen receptor alpha and beta; polycyclic musks; AHTN; HHCB; (anti)estrogenicity; 4-hydroxytamoxifen;
D O I
10.1006/taap.2002.9458
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the past decade the list of chemicals in the environment that are able to mimic the natural hormone estrogen, thereby disrupting endocrine function, has grown rapidly. These chemicals are able to bind to estrogen receptors (ERs) and influence estrogen signaling pathways, although several of them have structures that differ substantially from the endogenous hormone 17beta-estradiol. Because of their polycyclic nature, the polycyclic musks AHTN (6-acetyl-1,1,2,4,4,7-hexamethyltetraline) and HHCB (1,2,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta -gamma-2-benzopyran) were assessed for interaction with estrogen receptors. These compounds are ubiquitously present in surface waters and have been identified in human milk fat and blood. Using sensitive in vitro reporter gene assays, we found that AHTN and HHCB act as selective estrogen receptor modulators (SERMs), inducing both estrogenic and antiestrogenic activity dependent on the cell line and the ER subtype targeted. Weak estrogenic effects were observed only at relatively high concentrations (10muM). Antiestrogenic effects were observed in various cell lines starting at concentrations of 0.1 muM. In comparison with the well-known SERM, 4-hydroxytamoxifen, AHTN and HHCB have a much lower potency in suppressing estradiol-induced transactivation. Results with various mutant ER receptor types suggest that binding sites of the musk compounds differ from 17beta-estradiol and 4-hydroxytamoxifen. The cell type dependency of ER transactivation shows that caution should be exerted when interpreting effects of estrogenic compounds using in vitro systems. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ
    Routledge, EJ
    White, R
    Parker, MG
    Sumpter, JP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) : 35986 - 35993
  • [42] Estrogen receptor (ER)-β isoforms:: A key to understanding ER-β signaling
    Leung, Yuet-Kin
    Mak, Paul
    Hassan, Sazzad
    Ho, Shuk-Mei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (35) : 13162 - 13167
  • [43] Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity
    O'Boyle, Niamh M.
    Barrett, Irene
    Greene, Lisa M.
    Carr, Miriam
    Fayne, Darren
    Twamley, Brendan
    Knox, Andrew J. S.
    Keely, Niall O.
    Zisterer, Daniela M.
    Meegan, Mary J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (02) : 514 - 534
  • [44] Estrogen Receptor α (ERα) and Estrogen Related Receptor α (ERRα) are both transcriptional regulators of the Runx2-I isoform
    Kammerer, Martial
    Gutzwiller, Sabine
    Stauffer, Daniela
    Delhon, Isabelle
    Seltenmeyer, Yves
    Fournier, Brigitte
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2013, 369 (1-2) : 150 - 160
  • [45] Transcriptional activation by estrogen receptor (ERα) and steroid receptor coactivator (SRC1) involves distinct mechanisms in yeast and mammalian cells
    Sheppard, HM
    Matsuda, S
    Harries, JC
    Kindle, KB
    Heery, DM
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2003, 30 (03) : 411 - 422
  • [46] ICCVAM proposed substances for the validation of in vitro estrogen receptor (ER) and androgen receptor (AR) binding and transcriptional activation (TA) assays.
    Stokes, WS
    Shane, BS
    Inhof, CJ
    Tice, RR
    Hattan, D
    Wind, M
    TOXICOLOGICAL SCIENCES, 2003, 72 : 221 - 221
  • [47] Analysis of estrogen receptor (ERα and ERβ) and progesterone receptor (PR) polymorphisms in uterine leiomyomas
    Massart, Francesco
    Becherini, Lucia
    Marini, Francesca
    Noci, Ivo
    Piciocchi, Luigi
    Del Monte, Francesca
    Masi, Laura
    Falchetti, Alberto
    Tanini, Annalisa
    Scarselli, Gianfranco
    Brandi, Maria Luisa
    MEDICAL SCIENCE MONITOR, 2003, 9 (01): : BR25 - BR30
  • [48] Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain
    Shughrue, PJ
    Scrimo, PJ
    Merchenthaler, I
    NEUROSCIENCE, 2000, 96 (01) : 41 - 49
  • [49] Transcriptional regulation through the estrogen receptor (ER)-α and splice variants of ER-β via classical and nonclassical signal transduction pathways
    B Hanstein
    T Flötotto
    D Luke
    D Niederacher
    HG Bender
    Breast Cancer Research, 3 (Suppl 1)
  • [50] The gad2 Promoter Is a Transcriptional Target of Estrogen Receptor (ER) α and ERβ: A Unifying Hypothesis to Explain Diverse Effects of Estradiol
    Hudgens, Edward D.
    Ji, Lan
    Carpenter, Clifford D.
    Petersen, Sandra L.
    JOURNAL OF NEUROSCIENCE, 2009, 29 (27): : 8790 - 8797